Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INCB081776 |
Trade Name | |
Synonyms | INCB-081776 |
Drug Descriptions |
INCB081776 is a dual inhibitor of Axl and Mer that blocks TAM family kinase signaling, which may results in enhanced anti-tumor immunity (Cancer Res 2018;78(13 Suppl):Abstract nr 3759). |
DrugClasses | AXL Inhibitor 30 |
CAS Registry Number | NA |
NCIT ID | C153122 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
INCB081776 | INCB081776 | 0 | 1 |
INCB081776 + Nivolumab | INCB081776 Nivolumab | 0 | 1 |
INCB081776 + Pembrolizumab | INCB081776 Pembrolizumab | 0 | 1 |
INCB081776 + unspecified PD-L1 antibody | INCB081776 unspecified PD-L1 antibody | 0 | 0 |